臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"余明隆"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 151-175 of 304 (13 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
高雄醫學大學	2007	Hyperlipidemia in noise-induced hearing loss	張寧家;余明隆;何坤瑤;何啟功* ; Chang, NC;Yu, ML;Ho, KY;CK* , Ho
高雄醫學大學	2007	Hepatitis C viremia increases risk of type 2 diabetes mellitus in a hepatitis B and C endemic area	黃志富;余明隆;莊萬隆;戴嘉言;何啟功;李立柏;謝明彥;林子堯;陳信成;謝明裕;辛錫璋;張文宇
高雄醫學大學	2007	Epidemiological link between viral hepatitis infections and proteinuria in Taiwan	莊萬龍;黃志富;余明隆;戴嘉言;何啟功;Hwang, Shang-Jyh;陳信成;林子堯;王良彥;張文宇
高雄醫學大學	2007	The HBV Infection Among Aboriginal Children 20 Years After Immunization In Taiwan	莊萬龍;余明隆;戴嘉言;何啟功;黃釧峰;侯乃仁;李立柏;謝明彥;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇
高雄醫學大學	2007	山地醫療服務提昇計畫執行經驗	戴嘉言;余明隆;何啟功;黃洽鑚
高雄醫學大學	2007	高雄縣慢性腎臟病流行病學調查與現況分析-初步分析結果	黃尚志;莊弘毅;黃志中;林明彥;尤慧燕;邱怡文;黃素貞;李素珠;余明隆;李建宏;魏幸瑜;洪秀勳;徐瑞祥;陳鴻鈞
高雄醫學大學	2007	干安能治療B型肝炎引起失償非肝硬化病患早期死亡率及反應-以MELD及INDEX指標評估	戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍
高雄醫學大學	2007	The antinuclear antibody is associated with lower RNA levels of hepatitis C virus and more advanced fibrosis in chronic hepatitis C patients	謝明彥;黃志富;侯乃仁;戴嘉言;李立柏;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍;余明隆
高雄醫學大學	2007	Almost all HCV G2 Pts With Rapid Virologic Response at Wk 4 Achieve a SVR With 16 Wks of Treatment	余明隆;戴嘉言;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍
高雄醫學大學	2007	膽固醇主動輸出蛋白質(ABCG8)之基因多型性D19H和高膽固醇血症相關	蕭壁容;陳志成;余明隆;林昆德;王巧伶;辛錫璋
高雄醫學大學	2007	Outcome of chronic hepatitis C patients who required early termination of peginterferon-alfa plus ribavirin combination therapy	余明隆;戴嘉言;謝明彥;黃志富;張文宇;莊萬龍
高雄醫學大學	2007	Evaluation of the Abbott HCV RealTime PCR Assay for quantification of HCV viral loads	莊萬龍;黃志富;余明隆;戴嘉言;李立柏;謝明彥;林子堯;陳信成;謝明裕;張文宇
高雄醫學大學	2007	Human leukocyte antigen class I and II alleles and response to peginterferon plus ribavirin combination therapy in chronic hepatitis C patients	莊萬龍;戴嘉言;謝明彥;黃志富;張文宇;余明隆
高雄醫學大學	2007	Different Features In Liver Histopathology Of HCV Monoinfection And HCV/HBV Dual Infection	李立柏;余明隆;戴嘉言;侯乃仁;謝明彥;林子堯;陳信成;謝明裕;王良彥;Chen, Tong-Jong;張文宇;莊萬龍
高雄醫學大學	2007	The Seroprevalence Of HBV And HCV Infection In Southern Taiwan- Large Scale Community-Based Study	莊萬龍;余明隆;戴嘉言;林嘉益;侯乃仁;李立柏;謝明彥;黃志富;謝明裕;張文宇
高雄醫學大學	2007	Transforming Growth Factor-Beta 1 Gene Polymorphisms In High Dose IFN/Ribavirin treated CHC Patients	戴嘉言;余明隆;張文宇;李立柏;潘文正;侯乃仁;謝明彥;黃志富;陳信成;林子堯;謝明裕;王良彥;莊萬龍
高雄醫學大學	2007	Early Mortality And Responses In Non-Cirrhotic Decompensated CHB Patients With Lamivudine Therapy	戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;陳信成;王良彥;張文宇;莊萬龍
高雄醫學大學	2007	EARLY MORTALITY AND RESPONSES IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORS	戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍
高雄醫學大學	2007	The presence of Antinuclear Antibody is associated with a negative response to combination therapy with peginterferon and ribavirin for patients without genotype 1 chronic hepatitis C infection	謝明彥;戴嘉言;黃志富;莊萬龍;侯乃仁;李立柏;陳信成;謝明裕;王良彥;張文宇;余明隆
高雄醫學大學	2007	Pretreatment insulin sensitivity contributes to the treatment response to peginterferon plus ribavirin combination therapy for patients with chronic hepatitis C	黃志富;余明隆;戴嘉言;張文宇;莊萬龍
高雄醫學大學	2007	CLINICAL EVALUATION OF THE ABBOTT REAL-TIME PCR ASSAY FOR QUANTIFICATION OF HEPATITIS C VIRUS INFECTION AMONG GENOTYPE-1 AND -2 PATIENTS IN TAIWAN- COMPARISON TO THE VERSANT HCV RNA 3.0 ASSAY	戴嘉言;黃志富;余明隆;莊萬龍;張文宇
高雄醫學大學	2007	High chance of cure in HCV genotype 1 patients with a low viral load achieving an RVR treated for 24 wks with pegylated interferon alfa-2a (PEGASYS) plus ribavirin (COPEGUS): Prospective, randomized, controlled study comparing 24 & 48 wks of treatm	余明隆;戴嘉言;黃志富;李立柏;謝明彥;丘長富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍*
高雄醫學大學	2007	PHARMACOGENOMICS STUDY FOR 24 VS. 48 WEEKS TREATMENT OF PEGINTERFERON PLUS RIBAVIRIN FOR GENOTYPE 1b CHRONIC HEPATITIS C	戴嘉言;黃志富;謝明彥;陳信成;余明隆;莊萬龍
高雄醫學大學	2007	RELATIONSHIP BETWEEN GLUCOSE ABNORMALITIES AND RESPONSE TO PEGYLATED INTERFERON ALFA PLUS RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C PATIENTS	謝明彥;戴嘉言;黃志富;林子堯;余明隆;莊萬龍
高雄醫學大學	2007	PRETREATMENT INSULIN RESISTANCE WAS ASSOCIATED WITH RESPONSE TO COMBINATION THERAPY WITH PEGYLATED INTERFERON ALFA AND RIBAVIRIN IN NON-DIABETIC PATIENTS WITH CHRONIC HEPATITIS C	余明隆;戴嘉言;黃志富;李立柏;王良彥;莊萬龍

Showing items 151-175 of 304 (13 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2823486
	???header.visitor??? : 30327144 ???header.onlineuser??? : 941 ???header.sponsordeclaration???